Role of Mustakadi Vati in the management of Grahani Dosha

MANAGEMENT OF GRAHANI DOSHA WITH MUSTAKADI VATI AND BHUNIMBADI VATI IN CHILDREN AN OPEN LABELLED RANDOMIZED CONTROLLED CLINICAL TRIAL - MGDMVABVC

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/12/010847

Enrollment

Registered

2017-12-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having sign and symptoms of Grahani dosha

Interventions

Intervention1: In Group A Mustakadi vati 9 tablets mean dose per day in three divided dose orally for 8 weeks referance Bhavprakash Madhyam Khand Grahani Chikitsa sthana Shlok no 4/57 : 4 Drugs Musta

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age 5 to 10 years of either sex 2 Muhurbaddhama muhurdravama Irregular malapravritti 3 Udara shoola abdominal pain 4 Praseka salivation 5 Vishtambha constipation 6 Aruchi anorexia

Exclusion criteria

Exclusion criteria: 1 Children below 05 years and above 10 years of age 2 Patients having worm infestation infectious disease 3 Congenital anomalies 4 Hereditary diseases

Design outcomes

Primary

Measure	Time frame
Relieve in the sign and symptom of Grahani doshaTimepoint: 8 weeks	—

Secondary

Measure	Time frame
Relieve in the sign and symptom of Grahani doshaTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactDr V K Kori

IPGT AND RA JAMNAGAR

drkspatel2007@yahoo.co.in9427574566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026